Clínic Barcelona

Hospital Clínic implements the liquid biopsy to enhance clinical trials in oncology

Hospital Clínic of Barcelona will apply the leading comprehensive liquid biopsy test currently available for patients with advanced cancer, in the context of clinical trials. The Medical Oncology Department, together with the Anatomic Pathology Department, has reached an agreement with the company Guardant Health, headquartered in the United States, that will allow the genetic evaluation in the blood of patients who have advanced cancer to identify targeted therapies which are more precise.

Keep reading about: